New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
16:22 EDTARO, SIRI, CELG, SBUX, LMCA, ULTA, GMCROn The Fly: Closing Wrap
Stocks on Wall Street were lower following another session dominated by headlines concerning the geopolitical situation. Stocks were lower early in the session following the lower than expected University of Michigan consumer confidence reading. The market moved in a narrow range and crossed back and forth across the flat-line several times. Investors remain on edge following several recent poor economic reports out of China and frequent remainders of the upcoming elections in the Ukraine on Sunday. ECONOMIC EVENTS: In the U.S., producer prices fell 0.1% overall in February, versus an expected increase of 0.2%. The core reading, which excludes food and energy, fell 0.2%, versus an expected increase of 0.1%. The Reuters/University of Michigan Consumer Sentiment Survey for March unexpectedly dropped to a four-month low of 79.9. The preliminary reading for the month was expected by analysts to have come in at 81.8, which would have been a slight bump from the prior 81.6 figure. In Europe, citizens of the Crimea region of the Ukraine are likely to vote to secede this weekend, even as Ukraine, the U.S and the European Union maintain that the vote is illegal. U.S. Secretary of State John Kerry said he was told that Vladimir Putin is not prepared to make any decision regarding Ukraine until after the country's referendum. COMPANY NEWS: Liberty Media (LMCA) shares gained $9.11, or 7.22%, to $135.25 after the company announced last night that it plans to reclassify its common stock into two tracking stocks, one called Liberty Media Group and the other called Liberty Broadband Group. Liberty President & CEO Greg Maffei called the move "another step in Liberty’s process of offering investors greater choice, transparency and focus." Liberty said in conjunction with the plan that it would drop plans to buy the rest of Sirius XM (SIRI), in which it currently holds a 53% stake in. Sirius XM had previously suspended its stock repurchase program in connection with Liberty Media's proposal and it announced today that it now intends to resume the repurchase plan. Shares of Sirius advanced 7c, or 2.08%, to $3.44 following the news. MAJOR MOVERS: Among the notable gainers was beauty retailer Ulta Salon (ULTA), which advanced $5.75, or 6.42%, to $95.26 after the company’s fourth quarter results beat estimates. Also higher were shares of single-serve coffee machine maker Keurig Green Mountain (GMCR), which rose $7.09, or 6.68%, to $113.25 after the company agreed to new terms in its deal with coffee giant Starbucks (SBUX). Among the noteworthy losers was teen retailer Aeropostale (ARO), which dropped $1.47, or 20.14%, to $5.83 after its fourth quarter results and first quarter outlook missed analysts' consensus expectations and the company entered a financing deal with private equity firm Sycamore Partners. Also lower were shares of drug maker Celgene (CELG), which dropped $6.59, or 4.22%, to $149.41 after the U.K.'s healthcare guidance body issued new draft guidance on the use of the company's Revlimid drug. INDEXES: The Dow fell 43.22, or 0.27%, to 16,065.67, the Nasdaq dropped 15.02, or 0.35%, to 4,245.40, and the S&P 500 declined 5.21, or 0.28%, to 1,841.13.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
October 2, 2015
09:13 EDTGMCROn The Fly: Pre-market Movers
HIGHER: Wynn Resorts (WYNN), up 6.7% after reports indicate Chinese government may enact new policies to support Macau's economy. Shares of fellow Macau casino operators Las Vegas Sands (LVS) and MGM Resorts (MGM) are also higher in pre-market trading. UP AFTER EARNINGS: Micron (MU), up 3.3%... CalAmp (CAMP), up 9%. DOWN AFTER EARNINGS: Progress Software (PRGS), down 14.5%. ALSO LOWER: Valeant (VRX), down 4.5% after being downgraded to Equal Weight from Overweight at Morgan Stanley... Keurig Green Mountain (GMCR), down 3.4% after disclosing that its president of U.S. sales and marketing resigned... AIG (AIG), down 3% after being downgraded to Market Perform from Outperform at FBR Capital... Gilead (GILD), down 2% following a downgrade to Equal Weight at Morgan Stanley.
October 1, 2015
19:23 EDTGMCROn The Fly: After Hours Movers
UP AFTER EARNINGS: CalAmp (CAMP), up 9%... Micron Technology (MU), up 7%. ALSO HIGHER: bebe stores (BEBE), up 12.7% after reaffirming its first quarter guidance and announcing that its September Same Store Sales turned positive... Coherus Biosciences (CHRS), up 7.5% after CHS-1701 PK/PD study met primary PD endpoints... Nordstrom (JWN), up 3.6% after announcing a special cash dividend and additional $1B repurchase program. DOWN AFTER EARNINGS: Progress Software (PRGS), down 15.7%. ALSO LOWER: Keurig Green Mountain (GMCR), down 3.1% after disclosing the that president of U.S. sales and marketing, John Whoriskey, resigned... T-Mobile (TMUS), down 1.4% after Experian (EXPGY) disclosed a data breach affecting T-Mobile customers... XenoPort (XNPT), down 5.2% after announcing that the company will discontinue the development of XP23829.
18:52 EDTCELGCelgene could climb 35%, Barron's says
Celgene shares could climb 35% and shares look like a buy at current prices, Barron's contends in its 'Barron's Take' column. Reference Link
17:14 EDTGMCRKeurig Green Mountain discloses departure of president of U.S. sales, marketing
Subscribe for More Information
11:53 EDTSBUXDunkin' Brands sinks after announcing plans to close 100 U.S. stores
Shares of Dunkin' Brands (DNKN), a franchisor of quick service restaurants specializing in coffee and baked goods, are falling after the company projected third quarter U.S. same-store sales that fell below the prior year period. Additionally, Dunkin' said it would close 100 stores in the U.S. in 2015 and 2016. WHAT'S NEW: This morning during its Investor & Analyst Day presentation, Dunkin' Brands repeated its adjusted earnings per share guidance for fiscal year 2015 of $1.87-$1.91, below analysts' consensus of $1.92. Revenue for the fiscal year is seen increasing 6%-8%, compared to the consensus of $808.07M. The company also repeated its FY15 Dunkin' Donuts U.S. SSS guidance of up 1%-3% and Baskin-Robbins U.S. SSS up 1%-3%. Looking further ahead, Dunkin' Brands said it is targeting up to 15% adjusted EPS growth over the next 5 years along with mid to high single digit revenue growth and 10%+ adjusted operating income growth. It's also targeting U.S. comps growth of 2%-4% over the next five years along with total net unit development of 4%-6%. WHAT'S NOTABLE: Dunkin' estimated that same-store sales will grow 1.1% in Q3 at its U.S. Dunkin' Donuts stores compared with a 2% increase in the year-ago period. Additionally, the company said it expects to close 100 Dunkin' Donuts U.S. stores in 2015 and 2016. Dunkin' noted that its gross openings forecast remains unchanged. PRICE ACTION: In late morning trading, Dunkin' Brands fell $5.34, or about 10.8%, to $43.71 on more than four times its average daily trading volume. Including today's pull back, the shares have lost approximately 1% over the past 12 months. OTHERS TO WATCH: Dunkin' Brands peers include Starbucks (SBUX) and Panera Bread (PNRA), which are down 0.1% and 1.05%, respectively.
10:00 EDTCELGOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AMEC Foster Wheeler (AMFW) upgraded to Neutral from Underperform at Macquarie... Ares Capital (ARCC) upgraded to Outperform from Neutral at Macquarie... Celgene (CELG) upgraded to Overweight from Neutral at JPMorgan... Deutsche Boerse (DBOEY) upgraded to Overweight from Underweight at Barclays... Devon Energy (DVN) upgraded on valuation, catlysts at Bernstein... HeartWare (HTWR) upgraded to Market Perform from Underperform at Northland... IBERIABANK (IBKC) upgraded to Buy from Hold at Sandler O'Neill... (JD) upgraded to Buy from Hold at Deutsche Bank... Kirby (KEX) upgraded to Neutral from Underperform at Macquarie... Madison Square Garden (MSG) upgraded to Buy from Hold at Jefferies... Microsoft (MSFT) upgraded to Neutral from Underperform at BofA/Merrill... Newell Rubbermaid (NWL) upgraded to Buy from Neutral at B. Riley... Norfolk Southern (NSC) upgraded to Outperform from Peer Perform at Wolfe Research... Pernod Ricard (PDRDY) upgraded to Buy from Neutral at Goldman... RWE AG (RWEOY) upgraded to Sector Perform from Underperform at RBC Capital... SanDisk (SNDK) upgraded to Overweight from Equal Weight at Morgan Stanley... Steven Madden (SHOO) upgraded to Outperform ahead of earnings turn at Telsey Advisory... Trex Company (TREX) upgraded to Strong Buy from Buy at CL King... Universal Health (UHS) upgraded to Overweight from Sector Weight at KeyBanc... Western Digital (WDC) upgraded on transaction, valuation, momentum at Argus... Workday (WDAY) upgraded to Overweight from Equal Weight at Stephens.
08:33 EDTCELGAfter massive selloff, large biotechs seen leading sector back
The biotech sector has been among the worst performing groups during the recent stock market volaility, due to broader macroeconomic concerns as well as sector-specific worries about pushback on drug price increases. However, analysts at JPMorgan and Piper Jaffray issued notes defending a leader in the space, Celgene (CELG), and argued that growth in the sector will continue and cannot be ignored by investors for much longer. BUY CELGENE: JPMorgan analyst Cory Kasimov upgraded Celgene to Overweight citing an "increasingly attractive" valuation following the recent pullback in shares. The company is one the "most fundamentally sound biotechs" and shares at current levels are "too compelling to remain on the sidelines," Kasimov tells investors in a research note. The analyst said that not only does Celgene have an "impressive" proprietary pipeline, but he is also confident in the company's ability to identify potentially first-in-class and best-in-class products to partner on or acquire to continue its growth. Kasimov keeps a $152 price target for the stock. HIGH-GROWTH: Piper Jaffray analyst Joshua Schimmer says recent weakness in the biopharma sector has created a "valuation discrepancy" versus non-growth, non-biopharma stocks that he hasn't seen for a number of years. The sector remains in a "prolonged growth cycle" driven by extended product cycles, attractive and improving pipelines and M&A opportunities, Schimmer told investors in a research note titled "Out of The Ashes, A Growth Sector Poised To Fly Higher." The analyst, who expects large-cap biopharma companies to lift the sector out of the recent weakness, listed Celgene, Alexion (ALXN), Amgen (AMGN) and Endo (ENDP) as his preferred growth names. PRICE ACTION: Celgene shares are down more than 8% over the past month, though the stock closed yesterday up $2.79 to $108.13. During September, Alexion declined 9%, Amgen dropped 9%, Endo fell 10% and the iShares NASDAQ Biotechnology Index ETF (IBB) slid more than 11%.
06:28 EDTCELGPiper sees 'highly compelling' entry points in large cap biopharma
Piper Jaffray analyst Joshua Schimmer says recent weakness in the biopharma sector has created a "valuation discrepancy" versus non-growth peers that he hasn't seen for a number of years. The sector remains in a "prolonged growth cycle" driven by extended product cycles, attractive and improving pipelines and M&A opportunities, Schimmer tells investors in a research note titled "Out of The Ashes, A Growth Sector Poised To Fly Higher." He expects large-cap biopharma companies to lift the sector out of the recent weakness. His preferred growth names include Celgene (CELG), Alexion (ALXN), Amgen (AMGN) and Endo (ENDP).
05:47 EDTCELGCelgene upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Cory Kasimov upgraded Celgene to Overweight citing an "increasingly attractive" valuation following the recent pullback in shares. The company is one the "most fundamentally sound biotechs" and shares at current levels are "too compelling to remain on the sidelines," Kasimov tells investors in a research note. He keeps a $152 price target for the stock. Celgene closed yesterday up $2.79 to $108.13. Shares are down 8% over the past month.
September 30, 2015
19:51 EDTSIRISirius XM blames T-Mobile towers for signal loss, WSJ says
Subscribe for More Information
17:30 EDTSBUXStarbucks is launching Mobile Order & Pay in the UK
Starbucks is launching Mobile Order & Pay in the UK, allowing customers to pre-order their favourite drinks and food in over 150 London stores and save time in the queue. The company said, "Rolling out from 1st of October, the new feature, available exclusively within the Starbucks App, offers customers greater convenience: the ability to customise their drink and food orders as well as time savings of up to 10-15 minutes. Using the App allows customers to order ahead from the Starbucks menu. Following confirmation, orders are immediately sent to the chosen local Starbucks store where baristas begin preparing the order and an approximate collection time is sent to the customer to pick up their order directly from their barista - skipping the queue. Users of the app are also rewarded with exclusive opportunities to earn Stars with the My Starbucks Rewards loyalty programme. The App has received a very positive response from customers in the United States where it has been available since December 2014. According to customer feedback, the App typically saves commuters and working people 10-15 minutes in their day; parents with young children find it easier to order ahead than stand in line, while speech and hearing-impaired customers have hailed the App as a 'game changer' in helping them to get their correct order, fast."
September 29, 2015
19:24 EDTAROAeropostale says considering reverse stock split to meet listing requirement
Subscribe for More Information
16:09 EDTAROAeropostale receives NYSE listing notice
Subscribe for More Information
11:11 EDTCELGStocks with call strike movement; CELG GILD
Subscribe for More Information
09:33 EDTULTAULTA Beauty downgraded to Peer Perform from Outperform at Wolfe Research
07:28 EDTGMCRKeurig CEO: Kold machine to drive long-term growth, Reuters reports
Subscribe for More Information
September 25, 2015
16:17 EDTCELGOn The Fly: Top stock stories for Friday
Stocks opened with sharp gains the day after Fed Chair Janet Yellen gave some clarity to the market by suggesting the Fed will most likely raise interest rates by the end of the year. During afternoon trading, the news flow slowed and the volume lightened on the buy side, leaving the sellers with the upper hand. The Nasdaq was the first index to move into negative territory, led by broad weakness in biotech stocks, while the Dow was helped to stay in the green by a big post-earnings move higher in Nike (NKE). The averages limped into the close, leaving the market with an interesting set-up to begin next week. Outside of stock news, it was certainly a headline packed day, as Speaker of the House John Boehner announced that he will resign at the end of October, Chinese President Xi Jinping continued his U.S. visit and Pope Francis addressed the United Nations while spending a second day in New York City. ECONOMIC EVENTS: In the U.S., the third estimate of second quarter GDP showed the economy grew 3.9% quarter-over-quarter, versus expectations for the GDP growth estimate to stay at 3.7%. Personal consumption in Q2 is now believed to have grown 3.6%, up from the prior estimate of 3.1%. The final University of Michigan consumer sentiment reading for September came in at 87.2, which was down from August's 91.9 but above the expected 86.2 reading... Federal Reserve Chair Janet Yellen said during a speech at UMass Amherst last night that the central bank remains inclined to hike rates this year. Yellen's remarks were incrementally hawkish, but welcomed by the market, since they helped clarify the message the Fed delivered a week ago. Of note, the Fed chair paused multiple times toward the end of her speech and received medical attention afterward, but returned to her regular schedule later in the evening, with the bank explaining that Yellen was dehydrated after a long day but was otherwise fine. COMPANY NEWS: Nike jumped $10.23, or 8.9%, to $125.02 after Thursday night's report of better than expected earnings and futures orders prompted numerous price target hikes at Street research firms. Additionally, Sterne Agee upgraded Nike to Buy from Neutral, saying it thinks the company is benefiting from its "global grass roots engagement with its customers," which enables it to meet its customers' needs and determine to what extent it can raise prices. The firm, which thinks that the company is continuing to gain share, has a $150 price target on the athletic gear giant... Biotech stocks, which were already having a bad week, ended the week on a down note, as the iShares NASDAQ Biotechnology Index (IBB) fell 4.9%, giving it a weekly decline of about 13%. Among the biggest large-cap losers in the space were Vertex (VRTX), which fell 7%, Regeneron (REGN), which dropped 6% and Celgene (CELG), which slid 4.8%. MAJOR MOVERS: Among the notable gainers was Jabil Circuit (JBL), which advanced $2.38, or 12.2%, to $21.88 after it reported higher than expected earnings and gave guidance for its November quarter that was significantly above expectations. Also higher was Cirrus Logic (CRUS), which gained $3.90, or 14.4%, to $31.03 after tear downs of Apple's (AAPL) iPhone 6S and 6S Plus led analysts to conclude that the chipmaker appears poised to obtain more revenue from the new devices than from the previous generation of the market-leading smartphone. Among the noteworthy losers was Finish Line (FINL), which fell $4.86, or 19.6%, to $19.91 after reporting second quarter revenue that missed expectations and saying it expects adjusted earnings this fiscal year to increase in a low single to mid single digits percentage from last year. Also lower following its earnings report was smartphone and software maker BlackBerry (BBRY), which slid 7.68% to $6.49 after the company posted a second quarter loss that was steeper than analysts expected. BlackBerry also confirmed press reports that it plans to launch a new phone that uses Google's (GOOG) Android operating system instead of its own proprietary BB10 OS. Shares of Aratana Therapeutics (PETX), which dropped $6.81, or 38.97%, to $10.68 after the company said that, based on "mixed clinical and scientific results," it does not believe that canine lymphoma products AT-004 and AT-005 in their current, first-generation forms will capture the desired lymphoma market opportunity. INDEXES: The Dow rose 113.35, or 0.7%, to 16,314.67, the Nasdaq fell 47.98, or 1.01%, to 4,686.50, and the S&P 500 added/slipped 0.90, or 0.05%, to 1,931.34.
07:22 EDTCELGEuropean Society for Medical Oncology to hold a conference
Subscribe for More Information
06:20 EDTSBUXStarbucks promises to raise wages in U.K. beginning in November, FT reports
Starbucks will raise its average wage in the U.K. beginning in November to just under GBP8 an hour, The Financial Times reports. Additionally, the company will offer interest-free loans to help staff members pay deposits on housing. Reference Link
05:21 EDTCELGCelgene's VIDAZA receives positive CHMP opinion
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use